アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/12/05 | 1,604 | 1,608 | 1,587.5 | 1,593 | -12.5 | -0.8% | 3,855,800 |
2024/12/04 | 1,606.5 | 1,609 | 1,595 | 1,605.5 | -14.5 | -0.9% | 4,088,400 |
2024/12/03 | 1,600 | 1,624.5 | 1,595 | 1,620 | +36 | +2.3% | 6,375,200 |
2024/12/02 | 1,570 | 1,589 | 1,564 | 1,584 | +22.5 | +1.4% | 4,225,100 |
2024/11/29 | 1,560 | 1,570 | 1,549 | 1,561.5 | -10 | -0.6% | 5,503,400 |
2024/11/28 | 1,562.5 | 1,574 | 1,555 | 1,571.5 | +4.5 | +0.3% | 3,743,400 |
2024/11/27 | 1,572 | 1,578.5 | 1,561.5 | 1,567 | -5 | -0.3% | 3,421,600 |
2024/11/26 | 1,568 | 1,572 | 1,552.5 | 1,572 | ±0 | ±0% | 4,036,300 |
2024/11/25 | 1,598 | 1,601.5 | 1,570 | 1,572 | +10 | +0.6% | 14,539,600 |
2024/11/22 | 1,575 | 1,577.5 | 1,559 | 1,562 | -10 | -0.6% | 5,561,900 |
2024/11/21 | 1,585 | 1,598.5 | 1,570 | 1,572 | -0.5 | ±0% | 5,667,600 |
2024/11/20 | 1,573.5 | 1,580.5 | 1,561.5 | 1,572.5 | +11.5 | +0.7% | 4,935,500 |
2024/11/19 | 1,578 | 1,585 | 1,544 | 1,561 | -53.5 | -3.3% | 10,715,900 |
2024/11/18 | 1,656 | 1,660 | 1,612 | 1,614.5 | -56 | -3.4% | 6,837,200 |
2024/11/15 | 1,672.5 | 1,692 | 1,668.5 | 1,670.5 | +3 | +0.2% | 7,002,400 |
2024/11/14 | 1,685 | 1,687 | 1,667.5 | 1,667.5 | -2.5 | -0.1% | 4,814,200 |
2024/11/13 | 1,705 | 1,706.5 | 1,663.5 | 1,670 | -39.5 | -2.3% | 8,468,300 |
2024/11/12 | 1,738.5 | 1,746.5 | 1,701.5 | 1,709.5 | -20 | -1.2% | 5,805,800 |
2024/11/11 | 1,715.5 | 1,730.5 | 1,711 | 1,729.5 | +14 | +0.8% | 3,854,100 |
2024/11/08 | 1,751.5 | 1,752.5 | 1,713 | 1,715.5 | -19 | -1.1% | 4,949,800 |
2024/11/07 | 1,735 | 1,745 | 1,712.5 | 1,734.5 | -8.5 | -0.5% | 6,292,000 |
2024/11/06 | 1,735 | 1,774.5 | 1,731.5 | 1,743 | +14 | +0.8% | 5,983,900 |
2024/11/05 | 1,700 | 1,747.5 | 1,699.5 | 1,729 | -52.5 | -2.9% | 7,318,000 |
2024/11/01 | 1,769.5 | 1,796.5 | 1,762 | 1,781.5 | -14 | -0.8% | 4,864,900 |
2024/10/31 | 1,809 | 1,810.5 | 1,763.5 | 1,795.5 | +6.5 | +0.4% | 10,152,700 |
2024/10/30 | 1,790 | 1,803 | 1,780 | 1,789 | -1.5 | -0.1% | 11,665,600 |
2024/10/29 | 1,747.5 | 1,792 | 1,741 | 1,790.5 | +55 | +3.2% | 6,313,800 |
2024/10/28 | 1,696.5 | 1,749 | 1,692.5 | 1,735.5 | -1 | -0.1% | 5,818,600 |
2024/10/25 | 1,757.5 | 1,760 | 1,728 | 1,736.5 | -24.5 | -1.4% | 2,757,500 |
2024/10/24 | 1,762.5 | 1,774 | 1,758 | 1,761 | -1 | -0.1% | 4,069,200 |
2024/10/23 | 1,768 | 1,782.5 | 1,759 | 1,762 | -16 | -0.9% | 3,248,600 |
2024/10/22 | 1,786 | 1,786 | 1,760 | 1,778 | -7 | -0.4% | 3,554,900 |
2024/10/21 | 1,762 | 1,788 | 1,755 | 1,785 | +23 | +1.3% | 4,305,000 |
2024/10/18 | 1,750 | 1,772 | 1,744.5 | 1,762 | +29 | +1.7% | 3,711,700 |
2024/10/17 | 1,723.5 | 1,741 | 1,717 | 1,733 | +22 | +1.3% | 4,528,300 |
2024/10/16 | 1,710 | 1,731.5 | 1,695 | 1,711 | -14.5 | -0.8% | 3,780,500 |
2024/10/15 | 1,747.5 | 1,756.5 | 1,723.5 | 1,725.5 | -25 | -1.4% | 4,950,300 |
2024/10/11 | 1,744 | 1,753.5 | 1,738.5 | 1,750.5 | -15.5 | -0.9% | 5,450,600 |
2024/10/10 | 1,761 | 1,771 | 1,750 | 1,766 | +19 | +1.1% | 2,951,800 |
2024/10/09 | 1,759.5 | 1,762 | 1,727 | 1,747 | +3 | +0.2% | 3,475,600 |
2024/10/08 | 1,747 | 1,751 | 1,717.5 | 1,744 | -15 | -0.9% | 5,461,400 |
2024/10/07 | 1,747 | 1,767 | 1,728.5 | 1,759 | +31 | +1.8% | 5,004,100 |
2024/10/04 | 1,720 | 1,729.5 | 1,714.5 | 1,728 | +5.5 | +0.3% | 3,360,400 |
2024/10/03 | 1,706.5 | 1,729 | 1,705 | 1,722.5 | +43 | +2.6% | 4,579,600 |
2024/10/02 | 1,666.5 | 1,679.5 | 1,659 | 1,679.5 | +3 | +0.2% | 4,378,600 |
2024/10/01 | 1,650 | 1,677 | 1,645.5 | 1,676.5 | +29.5 | +1.8% | 4,448,400 |
2024/09/30 | 1,650 | 1,653 | 1,621 | 1,647 | -62.5 | -3.7% | 8,602,100 |
2024/09/27 | 1,690 | 1,710.5 | 1,670 | 1,709.5 | -9.5 | -0.6% | 7,305,000 |
2024/09/26 | 1,729 | 1,732.5 | 1,704 | 1,719 | -21 | -1.2% | 9,414,000 |
2024/09/25 | 1,740 | 1,746 | 1,726 | 1,740 | +16.5 | +1% | 5,364,000 |
101~
150
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム